MOG (35-55) H2-IA-a/b 流式验证

靶点说明

MOG(35-55) 来自髓鞘少突胶质细胞糖蛋白myelin/oligodendrocyte glycoprotein 的多肽序列MEVGWYRSPFSRVVHLYRNGK，在C57小鼠由MHC-II型H2-IA-a/b呈递。单次注射MOG 35-55足以在C57小鼠中诱导严重的临床实验性自身免疫性脑脊髓炎（EAE）。MOG 35-55特异性T细胞系在TCR Vβ基因使用方面具有多样性。

HLA类型

H2-IA-a/b，C57小鼠MHC-II型

抗原和HLA的亲和力

NetMHCpan II 4.0  计算MEVGWYRSPFSRVVHLYRNGK与H2-IA-a/b亲和力为 558.64nM

产品类型和应用

产品类型	规格	价格
流式检测与分选	MGP(35-55) H2-IA-a/b PE / APC / Alexa Fluor 488	7200元/50ug, 11800元/100ug
磁珠分选	MGP(35-55) H2-IA-a/b 磁珠	8200元/50ug, 12800元/100ug
生物素化复合物	MGP(35-55) H2-IA-a/b-biotin	6800元/50ug, 11400元/100ug

实测结果

肽刺激PBMC后检测抗原特异性CD4+T细胞

MEVGWYRSPFSRVVHLYRNGK多肽刺激H2-IA-a/b 限制性PBMC后，使用MGP(35-55) H2-IA-a/b 四聚体和抗CD4-FITC抗体检测。下图左图为抗原肽MEVGWYRSPFSRVVHLYRNGK刺激组，右图为未加抗原肽刺激组。

靶点结合的TCR序列

请查看IEDB数据库

Receptor - IEDB Receptor ID	Chain 1 - Calculated V Gene	Chain 1 - Calculated D Gene	Chain 1 - Calculated J Gene	Chain 1 - CDR3 Curated	Chain 2 - Calculated V Gene	Chain 2 - Calculated D Gene	Chain 2 - Calculated J Gene	Chain 2 - CDR3 Curated
1805	TRAV9D-4			VYFCALRSYNFGF	TRBV16*04			ASSLDCGANP

相关文章

Reference - PMID	Reference - Journal	Reference - Date	Reference - Title
15114658	Eur J Immunol	2004	Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
16785554	J Immunol	2006	IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.
12807824	Int Immunol	2003	Protection from autoimmune brain inflammation in mice lacking IFN-regulatory factor-1 is associated with Th2-type cytokines.
10626667	J Neuroimmunol	2000	Anti-IL-12 antibody prevents the development and progression of multiple sclerosis-like relapsing--remitting demyelinating disease in NOD mice induced with myelin oligodendrocyte glycoprotein peptide.
8965116	J Neurol	1996	The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
12578856	Int Immunol	2003	Encephalitogenic activity of truncated myelin oligodendrocyte glycoprotein (MOG) peptides and their recognition by CD8+ MOG-specific T cells on oligomeric MHC class I molecules.
12604312	J Autoimmun	2003	Optimization of an animal model of experimental autoimmune encephalomyelitis achieved with a multiple MOG(35-55)peptide in C57BL6/J strain of mice.
16341241	Nat Med	2006	Lipid microarrays identify key mediators of autoimmune brain inflammation.
10441162	J Autoimmun	1999	Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis.
18209046	J Immunol	2008	In trans T cell tolerance diminishes autoantibody responses and exacerbates experimental allergic encephalomyelitis.
18354166	J Immunol	2008	Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen.
18684939	J Immunol	2008	CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis.
18582952	J Neuroimmunol	2008	Behavioral and pathological outcomes in MOG 35-55 experimental autoimmune encephalomyelitis.
18566399	J Immunol	2008	Lithium prevents and ameliorates experimental autoimmune encephalomyelitis.
18981103	J Immunol	2008	MHC variant peptide-mediated anergy of encephalitogenic T cells requires SHP-1.
19402218	Neuroreport	2009	Selective phosphodiesterase-3 inhibitor cilostazol ameliorates experimental autoimmune encephalomyelitis.
19443805	Stroke	2009	Recombinant T cell receptor ligand treats experimental stroke.
19299745	J Immunol	2009	Subtle affinity-enhancing mutations in a myelin oligodendrocyte glycoprotein-specific TCR alter specificity and generate new self-reactivity.
12616486	Eur J Immunol	2003	Heterozygous null mutation of myelin P0 protein enhances susceptibility to autoimmune neuritis targeting P0 peptide.
18349128	Am J Pathol	2008	Antigen-induced Pten gene deletion in T cells exacerbates neuropathology in experimental autoimmune encephalomyelitis.
18577591	Proc Natl Acad Sci U S A	2008	IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis.
18490725	J Immunol	2008	Induction of anergy by antibody blockade of TCR in myelin oligodendrocyte glycoprotein-specific cells.
17911594	J Immunol	2007	CD8 T cell responses to myelin oligodendrocyte glycoprotein-derived peptides in humanized HLA-A*0201-transgenic mice.
17384649	Nat Med	2007	Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation.
17207459	Biochem Biophys Res Commun	2007	A critical role of LFA-1 in the development of Th17 cells and induction of experimental autoimmune encephalomyelytis.
17964666	J Neuroimmunol	2007	Myelin oligodendrocyte glycoprotein peptide-induced experimental allergic encephalomyelitis and T cell responses are unaffected by immunoproteasome deficiency.
17202353	J Immunol	2007	Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
16990050	Clin Immunol	2007	Altered susceptibility to EAE in congenic NOD mice: Altered processing of the encephalitogenic MOG35-55 peptide by NOR/LtJ mice.
15699115	J Immunol	2005	Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.
16301640	J Immunol	2005	The ICOS molecule plays a crucial role in the development of mucosal tolerance.
15189735	Immunity	2004	Immunological unresponsiveness characterized by increased expression of CD5 on peripheral T cells induced by dendritic cells in vivo.
14624757	J Autoimmun	2003	The magnitude and encephalogenic potential of autoimmune response to MOG is enhanced in MOG deficient mice.
8943561	Int Immunol	1996	Antibody response in Lewis rats injected with myelin oligodendrocyte glycoprotein derived peptides.
17257899	Clin Immunol	2007	Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice.
16423348	Exp Neurol	2006	Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein.
15593305	Eur J Immunol	2005	Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis.
15728477	J Immunol	2005	Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen.
15682385	J Neurosci Res	2005	Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
15236747	J Autoimmun	2004	Regulation of experimental autoimmune encephalomyelitis by CD4+, CD25+ and CD8+ T cells: analysis using depleting antibodies.
14768043	Eur J Immunol	2004	An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
12816990	J Immunol	2003	Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
12620641	J Neuroimmunol	2003	Distinct immune regulation of the response to H-2b restricted epitope of MOG causes relapsing-remitting EAE in H-2b/s mice.
12817031	J Immunol	2003	Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice.
12391178	J Immunol	2002	Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis.
11869358	Immunol Cell Biol	2002	Experimental autoimmune encephalomyelitis induction in naive mice by dendritic cells presenting a self-peptide.
12811843	Eur J Immunol	2003	Activation of invariant NKT cells by alphaGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-gamma.
12417441	J Neuroimmunol	2002	Induction of autoimmune encephalomyelitis and uveitis in B6 and (B6 x SJL) mice by peptides derived from myelin/oligodendrocyte glycoprotein.
11390514	J Immunol	2001	Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice.
9973531	Cell Immunol	1999	IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice.
10556797	Eur J Immunol	1999	B cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide.
10477557	J Exp Med	1999	Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis.
10602017	Eur J Immunol	1999	Decreased severity of myelin oligodendrocyte glycoprotein peptide 33 - 35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR delta chain gene.
10464178	Int Immunol	1999	Genetic susceptibility or resistance to autoimmune encephalomyelitis in MHC congenic mice is associated with differential production of pro- and anti-inflammatory cytokines.
9670859	J Neuroimmunol	1998	Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and alpha/beta T cell-deficient C57BL/6 mice.
9794370	J Immunol	1998	B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
9771980	Autoimmunity	1998	Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.
9362528	J Exp Med	1997	Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells.
8898962	Eur J Immunol	1996	Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
8752946	J Immunol	1996	Analysis of the fine B cell specificity during the chronic/relapsing course of a multiple sclerosis-like disease in Lewis rats injected with the encephalitogenic myelin oligodendrocyte glycoprotein peptide 35-55.
17404272	J Immunol	2007	Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
11485734	Immunity	2001	Combination of gene delivery and DNA vaccination to protect from and reverse Th1 autoimmune disease via deviation to the Th2 pathway.
15372502	J Neurosci Res	2004	HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
15093551	Clin Immunol	2004	A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.
11937578	J Immunol	2002	De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
16951350	J Immunol	2006	Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells.
19700760	Am J Pathol	2009	Carcinoembryonic antigen-related cell adhesion molecule 1 modulates experimental autoimmune encephalomyelitis via an iNKT cell-dependent mechanism.
19625643	J Immunol	2009	CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
19540601	J Neuroimmunol	2009	Pathogenic MOG-reactive CD8+ T cells require MOG-reactive CD4+ T cells for sustained CNS inflammation during chronic EAE.
19286483	Int Immunopharmacol	2009	Decreased inflammation and augmented expression of trophic factors correlate with MOG-induced neuroprotection of the injured nigrostriatal system in the murine MPTP model of Parkinson's disease.
19535153	J Neuroimmunol	2009	Mice deficient for CCR6 fail to control chronic experimental autoimmune encephalomyelitis.
8557821	J Neuroimmunol	1995	The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat.
19949074	J Immunol	2010	IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.
19201476	Mol Immunol	2009	Transient decomplementation of mice delays onset of experimental autoimmune encephalomyelitis and impairs MOG-specific T cell response and autoantibody production.
19688809	J Gene Med	2009	FK506 as an adjuvant of tolerogenic DNA vaccination for the prevention of experimental autoimmune encephalomyelitis.
19795414	Eur J Immunol	2009	Haptoglobin deficiency facilitates the development of autoimmune inflammation.
20147531	J Neurosci	2010	CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis.
19879259	Exp Neurol	2010	B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
20070942	Exp Neurol	2010	Aggravated experimental autoimmune encephalomyelitis in IL-15 knockout mice.
20038601	J Exp Med	2010	Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1.
20164413	J Immunol	2010	Contribution of myelin autoantigen citrullination to T cell autoaggression in the central nervous system.
19912648	J Neuroinflammation	2009	Modulation of experimental autoimmune encephalomyelitis by endogenous annexin A1.
20167381	J Neuroimmunol	2010	Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress.
20077431	J Neurosci Res	2010	Therapeutic potential of experimental autoimmune encephalomyelitis by Fasudil, a Rho kinase inhibitor.
19789980	J Neuroimmune Pharmacol	2010	Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG.
20133787	Proc Natl Acad Sci U S A	2010	Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab')2.
20483764	J Immunol	2010	TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis.
20091246	J Neuroimmune Pharmacol	2010	S-nitrosoglutathione a physiologic nitric oxide carrier attenuates experimental autoimmune encephalomyelitis.
20546938	J Neuroimmunol	2010	Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope.
20663571	J Neuroimmunol	2010	A Lecinoxoid, an oxidized phospholipid small molecule, constrains CNS autoimmune disease.
20624940	J Immunol	2010	Regulatory B cells (B10 cells) and regulatory T cells have independent roles in controlling experimental autoimmune encephalomyelitis initiation and late-phase immunopathogenesis.
20546940	J Neuroimmunol	2010	Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
20641064	Ann Neurol	2010	B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity.
20857508	J Neurosci Res	2010	Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.
21078910	J Immunol	2010	Leptin modulates the survival of autoreactive CD4+ T cells through the nutrient/energy-sensing mammalian target of rapamycin signaling pathway.
20172692	J Autoimmun	2010	Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.
20933475	Clin Immunol	2010	The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood.
21209700	PLoS One	2010	Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
21273399	Int Immunol	2011	Antigen-specific splenic CD4+ and CD8+ regulatory T cells generated via the eye, suppress experimental autoimmune encephalomyelitis either at the priming or at the effector phase.
21289301	J Immunol	2011	Coronin 1-mediated naive T cell survival is essential for the development of autoimmune encephalomyelitis.
21220453	J Exp Med	2011	High prevalence of low affinity peptide-MHC II tetramer-negative effectors during polyclonal CD4+ T cell responses.
21469129	Eur J Immunol	2011	TCR-like antibodies distinguish conformational and functional differences in two- versus four-domain auto reactive MHC class II-peptide complexes.
21413005	Eur J Immunol	2011	Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells.
21628899	Biol Pharm Bull	2011	Relapse of experimental autoimmune encephalomyelitis after discontinuation of FTY720 (Fingolimod) treatment, but not after combination of FTY720 and pathogenic autoantigen.
21685327	J Immunol	2011	Role for MyD88, TLR2 and TLR9 but not TLR1, TLR4 or TLR6 in experimental autoimmune encephalomyelitis.
21738737	PLoS One	2011	Physiological induction of regulatory Qa-1-restricted CD8+ T cells triggered by endogenous CD4+ T cell responses.
21750737	PLoS One	2011	RTL551 treatment of EAE reduces CD226 and T-bet+ CD4 T cells in periphery and prevents infiltration of T-bet+ IL-17, IFN-γ producing T cells into CNS.
21246417	J Mol Neurosci	2011	Amelioration of experimental autoimmune encephalomyelitis by β-elemene treatment is associated with Th17 and Treg cell balance.
21767394	BMC Immunol	2011	Detection of autoreactive CD4 T cells using major histocompatibility complex class II dextramers.
21897850	PLoS One	2011	BAFF promotes Th17 cells and aggravates experimental autoimmune encephalomyelitis.
21846799	Endocrinology	2011	GH, but not GHRH, plays a role in the development of experimental autoimmune encephalomyelitis.
21674137	J Clin Immunol	2011	A distinct role of CD4+ Th17- and Th17-stimulated CD8+ CTL in the pathogenesis of type 1 diabetes and experimental autoimmune encephalomyelitis.
9083925	J Mol Med (Berl)	1997	Myelin oligodendrocyte glycoprotein: a novel candidate autoantigen in multiple sclerosis.
22208499	BMC Immunol	2011	Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).
22044096	Immunology	2012	Regulatory T cells play a role in T-cell receptor CDR2 peptide regulation of experimental autoimmune encephalomyelitis.
21702922	J Neuroinflammation	2011	Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
22288774	J Neurochem	2012	The vincamine derivative vindeburnol provides benefit in a mouse model of multiple sclerosis: effects on the Locus coeruleus.
21647172	Immunol Cell Biol	2012	SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
22548151	Autoimmune Dis	2012	Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
22392628	Metab Brain Dis	2012	Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis.
22566807	Front Immunol	2011	Recognition of a high affinity MHC class I-restricted epitope of myelin oligodendrocyte glycoprotein by CD8? T cells derived from autoantigen-deficient mice.
22586035	J Immunol	2012	A switch in pathogenic mechanism in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in IFN-γ-inducible lysosomal thiol reductase-free mice.
22279107	J Immunol	2012	A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells.
22745170	Proc Natl Acad Sci U S A	2012	Nanoparticle-mediated codelivery of myelin antigen and a tolerogenic small molecule suppresses experimental autoimmune encephalomyelitis.
22688423	J Neuroimmunol	2012	Sustained Rap1 activation in autoantigen-specific T lymphocytes attenuates experimental autoimmune encephalomyelitis.
22912731	PLoS One	2012	Quetiapine, an atypical antipsychotic, is protective against autoimmune-mediated demyelination by inhibiting effector T cell proliferation.
22973070	J Chem Technol Biotechnol	2005	Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.
22943418	J Neuroinflammation	2012	IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.
22969072	Invest Ophthalmol Vis Sci	2012	Visual functional and histopathological correlation in experimental autoimmune optic neuritis.
23056200	PLoS One	2012	Increased synapse formation obtained by T cell epitopes containing a CxxC motif in flanking residues convert CD4+ T cells into cytolytic effectors.
23077616	PLoS One	2012	Soluble MOG35-55/I-A(b) dimers ameliorate experimental autoimmune encephalomyelitis by reducing encephalitogenic T cells.
23033382	Invest Ophthalmol Vis Sci	2012	Interleukin-10 gene-transfected mature dendritic cells suppress murine experimental autoimmune optic neuritis.
23253693	J Neuroinflammation	2012	Sevoflurane reduces clinical disease in a mouse model of multiple sclerosis.
23121666	Clin Exp Immunol	2012	Characterization of the interaction between astrocytes and encephalitogenic lymphocytes during the development of experimental autoimmune encephalitomyelitis (EAE) in mice.
23294897	J Neuroimmunol	2013	Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35-55.
16890924	Cell Immunol	2006	Modulation of MOG 37-50-specific CD8+ T cell activation and expansion by CD43.
18802481	J Clin Invest	2008	Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression.
19748894	J Biol Chem	2009	MKP-1 is necessary for T cell activation and function.
21199897	J Immunol	2011	Cutting edge: TIGIT has T cell-intrinsic inhibitory functions.
22363608	PLoS One	2012	Preformed CD40L is stored in Th1, Th2, Th17, and T follicular helper cells as well as CD4+ 8- thymocytes and invariant NKT cells but not in Treg cells.
22745378	J Immunol	2012	Transcriptional regulator Id2 is required for the CD4 T cell immune response in the development of experimental autoimmune encephalomyelitis.
18478523	Chembiochem	2008	Alpha-lactosylceramide as a novel "sugar-capped" CD1d ligand for natural killer T cells: biased cytokine profile and therapeutic activities.
23514872	J Autoimmun	2013	High-mobility group box 1 protein (HMGB1) neutralization ameliorates experimental autoimmune encephalomyelitis.
23686493	J Immunol	2013	Antigen-specific effector CD4 T lymphocytes school lamina propria dendritic cells to transfer innate tolerance.
23705890	J Neuroinflammation	2013	The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.
23733879	J Immunol	2013	The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis.
23300649	PLoS One	2012	Passive experimental autoimmune encephalomyelitis in C57BL/6 with MOG: evidence of involvement of B cells.
23799062	PLoS One	2013	Chloroquine treatment enhances regulatory T cells and reduces the severity of experimental autoimmune encephalomyelitis.
23720813	J Immunol	2013	LIGHT (TNFSF14/CD258) is a decisive factor for recovery from experimental autoimmune encephalomyelitis.
23945139	J Immunol	2013	Targeting of autoantigens to DEC205? dendritic cells in vivo suppresses experimental allergic encephalomyelitis in mice.
23772030	J Immunol	2013	Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.
24130809	PLoS One	2013	Genetic background can result in a marked or minimal effect of gene knockout (GPR55 and CB2 receptor) in experimental autoimmune encephalomyelitis models of multiple sclerosis.
24123687	J Immunol	2013	Small molecule inhibitor of antigen binding and presentation by HLA-DR2b as a therapeutic strategy for the treatment of multiple sclerosis.
24053384	J Neuroinflammation	2013	Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.
24084097	Mol Immunol	2014	A novel nanoparticle containing MOG peptide with BTLA induces T cell tolerance and prevents multiple sclerosis.
24338259	Iran J Allergy Asthma Immunol	2014	The role of interleukin-23 in stability of in vitro T helper-17 cells.
24111507	Clin Exp Immunol	2014	Blockade of tumour necrosis factor-α in experimental autoimmune encephalomyelitis reveals differential effects on the antigen-specific immune response and central nervous system histopathology.
24147816	ACS Chem Biol	2014	Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
24123686	J Immunol	2013	The role of CD8+ T cells and their local interaction with CD4+ T cells in myelin oligodendrocyte glycoprotein35-55-induced experimental autoimmune encephalomyelitis.
23876060	Immunology	2013	Novel pathogenic epitopes of myelin oligodendrocyte glycoprotein induce experimental autoimmune encephalomyelitis in C57BL/6 mice.
24238343	Immunity	2013	Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response.
24444311	J Neuroinflammation	2014	Cell-selective knockout and 3D confocal image analysis reveals separate roles for astrocyte-and endothelial-derived CCL2 in neuroinflammation.
23858035	J Immunol	2013	microRNA-17-92 regulates IL-10 production by regulatory T cells and control of experimental autoimmune encephalomyelitis.
24411589	Cytotherapy	2014	Human amniotic epithelial cells suppress relapse of corticosteroid-remitted experimental autoimmune disease.
24009768	PLoS One	2013	Artemisinin analogue SM934 ameliorates murine experimental autoimmune encephalomyelitis through enhancing the expansion and functions of regulatory T cell.
24683185	J Immunol	2014	HLA-DRα1 constructs block CD74 expression and MIF effects in experimental autoimmune encephalomyelitis.
24778444	J Immunol	2014	NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing.
24845797	Cytokine	2014	Ingested (oral) tocilizumab inhibits EAE.
21653838	J Neurosci	2011	Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
24868560	J Immunol Res	2014	Regulatory lymphocytes are key factors in MHC-independent resistance to EAE.
24924222	J Neuroinflammation	2014	Deletion of astroglial CXCL10 delays clinical onset but does not affect progressive axon loss in a murine autoimmune multiple sclerosis model.
24858261	Clin Immunol	2014	A Trichosanthin-derived peptide suppresses type 1 immune responses by TLR2-dependent activation of CD8(+)CD28(-) Tregs.
24220208	Immunol Lett	2014	T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
24869907	Mol Med	2014	Low-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cells.
25340074	Neurol Neuroimmunol Neuroinflamm	2014	Immunodominant T-cell epitopes of MOG reside in its transmembrane and cytoplasmic domains in EAE.
25617499	J Hepatol	2015	Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice.
26663200	J Pept Sci	2016	Epitope mapping of anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a mouse model of multiple sclerosis: microwave-assisted synthesis of the peptide antigens and ELISA screening.
27334749	Eur J Immunol	2016	Myelin oligodendrocyte glycoprotein induces incomplete tolerance of CD4(+) T cells specific for both a myelin and a neuronal self-antigen in mice.
27796368	Sci Rep	2016	Targeting Non-classical Myelin Epitopes to Treat Experimental Autoimmune Encephalomyelitis.
27976744	Nat Commun	2016	Low-affinity CD4+ T cells are major responders in the primary immune response.
28270614	Proc Natl Acad Sci U S A	2017	Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease.
28484224	Sci Rep	2017	Suppression of autoimmune demyelinating disease by preferential stimulation of CNS-specific CD8 T cells using Listeria-encoded neuroantigen.
16506290	Eur J Immunol	2006	Persistence of autoreactive myelin oligodendrocyte glycoprotein (MOG)-specific T cell repertoires in MOG-expressing mice.
18566378	J Immunol	2008	Retrogenic modeling of experimental allergic encephalomyelitis associates T cell frequency but not TCR functional affinity with pathogenicity.
28872108	J Vis Exp	2017	Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4.
27192577	Immunity	2016	Thymus-Derived Regulatory T Cells Are Positively Selected on Natural Self-Antigen through Cognate Interactions of High Functional Avidity.
28887429	J Immunol	2017	NFM Cross-Reactivity to MOG Does Not Expand a Critical Threshold Level of High-Affinity T Cells Necessary for Onset of Demyelinating Disease.
29258717	J Autoimmun	2018	Tolerogenic Ag-PLG nanoparticles induce tregs to suppress activated diabetogenic CD4 and CD8 T cells.
30941120	Front Immunol	2019	Abrogation of Endogenous Glycolipid Antigen Presentation on Myelin-Laden Macrophages by D-Sphingosine Ameliorates the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
32106283	J Exp Med	2020	A population of proinflammatory T cells coexpresses αβ and γδ T cell receptors in mice and humans.
32069316	PLoS Biol	2020	Lack of the MHC class II chaperone H2-O causes susceptibility to autoimmune diseases.
34716313	Cell Death Dis	2021	CD8<sup>+</sup> T cells specific for cryptic apoptosis-associated epitopes exacerbate experimental autoimmune encephalomyelitis.
34919442	Sci Immunol	2021	Humanization of T cell-mediated immunity in mice.
37463205	Proc Natl Acad Sci U S A	2023	T cell deletional tolerance restricts AQP4 but not MOG CNS autoimmunity.
36969215	Front Immunol	2023	Dendritic cell expression of CD24 contributes to optimal priming of T lymphocytes in lymph nodes.